KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Current Deferred Revenue: 2012-2014

Historic Current Deferred Revenue for TherapeuticsMD (TXMD) over the last 3 years, with Dec 2014 value amounting to $522,613.

  • TherapeuticsMD's Current Deferred Revenue fell 67.39% to $522,613 in Q4 2014 from the same period last year, while for Dec 2014 it was $522,613, marking a year-over-year decrease of 67.39%. This contributed to the annual value of $522,613 for FY2014, which is 67.39% down from last year.
  • Latest data reveals that TherapeuticsMD reported Current Deferred Revenue of $522,613 as of FY2014, which was down 67.39% from $1.6 million recorded in FY2013.
  • Over the past 5 years, TherapeuticsMD's Current Deferred Revenue peaked at $1.6 million during FY2013, and registered a low of $522,613 during FY2014.
  • Its 3-year average for Current Deferred Revenue is $1.1 million, with a median of $1.1 million in 2012.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first surged by 39.99% in 2013, then slumped by 67.39% in 2014.
  • Over the past 3 years, TherapeuticsMD's Current Deferred Revenue (Yearly) stood at $1.1 million in 2012, then skyrocketed by 39.99% to $1.6 million in 2013, then plummeted by 67.39% to $522,613 in 2014.